PHILADELPHIA, July 10, 2025 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Amicus Therapeutics, Inc. (NASDAQ: FOLD) ("Amicus") on behalf of the company's shareholders. Year to date, shares of Amicus' stock have declined over 32% in value, to trade at a current price of less than $7.00 per share. The investigation seeks to determine whether Amicus and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate ...